News

Applications now open for Professorship in Stem Cell Medicine

3 March 2023

The Wellcome-MRC Cambridge Stem Cell Institute and the School of Clinical Medicine are pleased to announce that applications are now welcome for the Professorship of Stem Cell Medicine. We are seeking candidates who have: the vision, leadership experience and enthusiasm to develop and maintain a leading research presence...

Dr Elisa Laurenti and Dr Daniel Hodson awarded ERC Grants

7 February 2023

Two CSCI Group Leaders are among the eight researchers from the University of Cambridge who were awarded European Research Council (ERC) Consolidator Grants last week. Dr Elisa Laurenti and Dr Daniel Hodson were selected from over 2,000 applicants for their research conducted at the Wellcome-MRC Cambridge Stem Cell...

Dr Harry Bulstrode joins team of Principal Investigators

CSCI Welcomes Dr Harry Bulstrode as new Group Leader

30 January 2023

Dr Harry Bulstrode joins us this week (1 February) as a Principal Investigator researching n eural stem cells in relation to development, regeneration and cancer. Dr Bulstrode joins us most recently from the Francis Crick Institute, where he studied glioma stem cell biology and the tumour microenvironment in malignant...

Apply now for Stem Cells IRC Small Grants

16 January 2023

The Stem Cells Interdisciplinary Research Centre (IRC) is currently inviting postgraduate researchers and postdoctoral research fellows to submit applications for research funding and training, rooted in stem cell research that fosters integration along disciplines. Eligibility The scheme is open to all postgraduate...

CSCI Scientists Sinha, Karadottir, and Sampaziotis. Credit: Alun Callender

CSCI scientists on regenerative medicine research

9 January 2023

Dr Thóra Káradóttir , Professor Andrew McCaskie , Dr Fotios Sampaziotis , and Professor Sanjay Sinha of the Wellcome-MRC Cambridge Stem Cell Institute (CSCI) were recently interviewed in CAM Magazine’s recent feature on regenerative medicine. Discussing their work on hearts, livers, joints, and brains, using cutting-edge...

CSCI welcomes new cohort of postgraduate students

8 December 2022

A total of 26 new Postgraduate students started at CSCI in October 2022, under the supervision of 11 different PIs within the Institute. These students are on a variety of PhD and Masters programmes, and are based in the following labs: Wellcome MRes + PhD Programme (currently doing rotations): 6 students CCMR MRes + PhD...

Off-patent liver disease drug could prevent COVID-19 infection

5 December 2022

Cambridge scientists from the Sampaziotis lab show that a widely used drug to treat liver disease can prevent COVID-19 infection or reduce disease severity Cambridge Stem Cell Institute scientists have identified an off-patent drug that can be repurposed to prevent COVID-19 – and may be capable of protecting against future...

Stem Cells IRC workshop winners announced

18 November 2022

Winners from the Collaboration Creation Days workshop have been awarded this week for their proposals presented at the end of the event. In September, the Wellcome-MRC Cambridge Stem Cell Institute Interdisciplinary Research Centre , together with Sensor CDT , Cambridge Centre for Physical Biology , and the Department of...

Removing a small cell sample during clinical trials

CSCI scientists take part in first ever clinical trial of lab-grown red blood cells transfused into another person

7 November 2022

Cambridge researchers are taking part in the world’s first clinical trial of red blood cells that have been grown in a laboratory for transfusion into another person. The manufactured blood cells were grown from stem cells from donors. The red cells were then transfused into volunteers in the RESTORE randomised controlled...

Clinical trial for new stem cell-based treatment for Parkinson’s disease to move forward

20 October 2022

Clinical trial for new stem cell-based Parkinson’s disease treatment to move forward Cambridge researchers will play a key role in clinical trials of a new treatment that involves transplanting healthy nerve cells into the brains of patients with Parkinson’s disease. The Swedish Medical Products Agency has granted approval...